These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 15510218

  • 1. Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer.
    Panne D, Maniatis T, Harrison SC.
    EMBO J; 2004 Nov 10; 23(22):4384-93. PubMed ID: 15510218
    [Abstract] [Full Text] [Related]

  • 2. Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation.
    Falvo JV, Parekh BS, Lin CH, Fraenkel E, Maniatis T.
    Mol Cell Biol; 2000 Jul 10; 20(13):4814-25. PubMed ID: 10848607
    [Abstract] [Full Text] [Related]

  • 3. Assembling the human IFN-beta enhanceosome in solution.
    Dragan AI, Carrillo R, Gerasimova TI, Privalov PL.
    J Mol Biol; 2008 Dec 12; 384(2):335-48. PubMed ID: 18823997
    [Abstract] [Full Text] [Related]

  • 4. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.
    Yie J, Merika M, Munshi N, Chen G, Thanos D.
    EMBO J; 1999 Jun 01; 18(11):3074-89. PubMed ID: 10357819
    [Abstract] [Full Text] [Related]

  • 5. Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer.
    Escalante CR, Nistal-Villán E, Shen L, García-Sastre A, Aggarwal AK.
    Mol Cell; 2007 Jun 08; 26(5):703-16. PubMed ID: 17560375
    [Abstract] [Full Text] [Related]

  • 6. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo.
    Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T.
    Mol Cell; 1998 Mar 08; 1(4):507-18. PubMed ID: 9660935
    [Abstract] [Full Text] [Related]

  • 7. An atomic model of the interferon-beta enhanceosome.
    Panne D, Maniatis T, Harrison SC.
    Cell; 2007 Jun 15; 129(6):1111-23. PubMed ID: 17574024
    [Abstract] [Full Text] [Related]

  • 8. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
    De Cesare D, Vallone D, Caracciolo A, Sassone-Corsi P, Nerlov C, Verde P.
    Oncogene; 1995 Jul 20; 11(2):365-76. PubMed ID: 7624151
    [Abstract] [Full Text] [Related]

  • 9. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription.
    Merika M, Williams AJ, Chen G, Collins T, Thanos D.
    Mol Cell; 1998 Jan 20; 1(2):277-87. PubMed ID: 9659924
    [Abstract] [Full Text] [Related]

  • 10. The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms.
    Du W, Maniatis T.
    Proc Natl Acad Sci U S A; 1994 Nov 22; 91(24):11318-22. PubMed ID: 7972056
    [Abstract] [Full Text] [Related]

  • 11. Stability and DNA-binding ability of the bZIP dimers formed by the ATF-2 and c-Jun transcription factors.
    Carrillo RJ, Dragan AI, Privalov PL.
    J Mol Biol; 2010 Feb 19; 396(2):431-40. PubMed ID: 19944700
    [Abstract] [Full Text] [Related]

  • 12. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome.
    Kim TK, Maniatis T.
    Mol Cell; 1997 Dec 19; 1(1):119-29. PubMed ID: 9659909
    [Abstract] [Full Text] [Related]

  • 13. Structural determinants outside of the leucine zipper influence the interactions of CREB and ATF-2: interaction of CREB with ATF-2 blocks E1a-ATF-2 complex formation.
    Abdel-Hafiz HA, Chen CY, Marcell T, Kroll DJ, Hoeffler JP.
    Oncogene; 1993 May 19; 8(5):1161-74. PubMed ID: 8479741
    [Abstract] [Full Text] [Related]

  • 14. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y).
    Falvo JV, Thanos D, Maniatis T.
    Cell; 1995 Dec 29; 83(7):1101-11. PubMed ID: 8548798
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements.
    Du W, Thanos D, Maniatis T.
    Cell; 1993 Sep 10; 74(5):887-98. PubMed ID: 8374955
    [Abstract] [Full Text] [Related]

  • 16. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7.
    Lin R, Génin P, Mamane Y, Hiscott J.
    Mol Cell Biol; 2000 Sep 10; 20(17):6342-53. PubMed ID: 10938111
    [Abstract] [Full Text] [Related]

  • 17. The enhanceosome.
    Panne D.
    Curr Opin Struct Biol; 2008 Apr 10; 18(2):236-42. PubMed ID: 18206362
    [Abstract] [Full Text] [Related]

  • 18. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.
    Guo B, Stein JL, van Wijnen AJ, Stein GS.
    Biochemistry; 1997 Nov 25; 36(47):14447-55. PubMed ID: 9398163
    [Abstract] [Full Text] [Related]

  • 19. Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3',5'-monophosphate response element-binding protein and related transcription factors.
    Kroll DJ, Sullivan DM, Gutierrez-Hartmann A, Hoeffler JP.
    Mol Endocrinol; 1993 Mar 25; 7(3):305-18. PubMed ID: 8387155
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta1 down-regulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors.
    Napolitano G, Montani V, Giuliani C, Di Vincenzo S, Bucci I, Todisco V, Laglia G, Coppa A, Singer DS, Nakazato M, Kohn LD, Colletta G, Monaco F.
    Mol Endocrinol; 2000 Apr 25; 14(4):486-505. PubMed ID: 10770487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.